Multiple ultrasound cavitation-enabled treatments for myocardial reduction
Open Access
- 9 November 2017
- journal article
- research article
- Published by Springer Nature in Journal of Therapeutic Ultrasound
- Vol. 5 (1) , 29
Abstract
Ultrasound myocardial cavitation enabled treatment (MCET) is an image-guided method for tissue reduction. In this study, a strategy of fractionated (multiple) treatments was tested for efficacy. Dahl SS rats were anesthetized and prepared for treatment with a focused ultrasound transducer in a warm water bath. Aiming at the anterior left ventricular wall was facilitated by imaging with a 10 MHz phased array (10S, GE Vivid 7, GE Vingmed Ultrasound, Horten, Norway). MCET was accomplished at 1.5 MHz by pulse bursts of 4 MPa peak rarefactional pressure amplitude, which were intermittently triggered 1:8 from the ECG during infusion of a microbubble suspension for cavitation nucleation. Test groups were sham, a 200 s treatment, three 200 s treatments a week apart, and a 600 s treatment. Treatment outcome was observed by plasma troponin after 4 h, echocardiographic monitoring and histology at 6 wk. The impacts of the fractionated treatments summed to approximately the same as the long treatment; e. g. the troponin result was 10.5 ± 3.2 for 200 s, 22.7 ± 5.4 (p < 0.001) for the summed fractionated treatments and 29.9 ± 6.4 for 600 s (p = 0.06 relative to the summed fractionated). While wall thickness was not reduced for the fractionated treatment, tissue strain was reduced by 35% in the target area relative sham (p < 0.001). The ability to fractionate treatment may be advantageous for optimizing patient outcome relative to all-or nothing therapy by surgical myectomy or alcohol ablation.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (114595)
This publication has 27 references indexed in Scilit:
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyJACC, 2011
- Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathyThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy and Sudden DeathCirculation: Cardiovascular Interventions, 2010
- Substitution of Brown Norway chromosome 16 preserves cardiac function with aging in a salt-sensitive Dahl consomic ratPhysiological Genomics, 2008
- Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathyHeart, 2006
- Hypertrophic cardiomyopathyCurrent Problems in Cardiology, 2004
- American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic CardiomyopathyJACC, 2003
- Familial Hypertrophic Cardiomyopathy in Maine Coon CatsCirculation, 1999
- Cumulative Troponin T Release after Acute Myocardial Infarction. Influence of ReperfusionClinical Chemistry and Laboratory Medicine (CCLM), 1997
- Relation of early mononuclear and polymorphonuclear cell infiltration to late scar thickness after experimentally induced myocardial infarction in the ratBasic Research in Cardiology, 1985